Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.

Fiche publication


Date publication

novembre 2016

Journal

European radiology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NOEL Georges, Pr TRUC Gilles


Tous les auteurs :
Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A

Résumé

To identify relevant relative cerebral blood volume biomarkers from T2* dynamic-susceptibility contrast magnetic resonance imaging to anticipate glioblastoma progression after chemoradiation.

Mots clés

Adult, Aged, Biomarkers, metabolism, Blood Volume, Brain Neoplasms, pathology, Chemoradiotherapy, methods, Contrast Media, Disease Progression, Female, Glioblastoma, pathology, Humans, Magnetic Resonance Imaging, methods, Male, Middle Aged, Neoplasm Recurrence, Local, pathology, Prospective Studies, ROC Curve

Référence

Eur Radiol. 2016 Nov;26(11):4194-4203